Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception

Human Reproduction
Scott M NelsonRichard Fleming

Abstract

Individualization of controlled ovarian stimulation (COS) for assisted conception is complicated by variable ovarian response to follicle stimulating hormone. We hypothesized that anti-Müllerian hormone (AMH), a predictor of oocyte yield, may facilitate treatment strategies for women undergoing COS, to optimize safety and clinical pregnancy rates. Prospective cohort study of 538 patients in two centres with differential COS strategies based on a centralized AMH measurement. AMH was associated with oocyte yield after ovarian stimulation in both centres, and a 'reduced' AMH (1 to <5 pmol/l) was associated with a reduced clinical pregnancy rate. Women with a 'normal' AMH (5 to <15 pmol/l) treated with a long GnRH-agonist protocol (both centres) showed a low incidence of excess response (0%) and poor response (0%). In women with 'high' AMH (>15 pmol/l), the antagonist protocol eliminated the need for complete cryopreservation of embryos due to excess response (P < 0.001) and showed a higher fresh cycle clinical pregnancy rate than agonist cycles [OR 4.40 (95% CI 1.95-9.93), P < 0.001]. The use of circulating AMH to individualize treatment strategies for COS may result in reduced clinical risk, optimized treatment burden and maintai...Continue Reading

References

Jan 1, 1982·British Journal of Obstetrics and Gynaecology·R FlemingJ R Coutts
Mar 25, 2000·Fertility and Sterility·C L CookM E Fallat
Aug 30, 2000·Molecular and Cellular Endocrinology·M J Faddy
Apr 2, 2002·Human Reproduction·Hesham Al-Inany, Mohamed Aboulghar
Nov 29, 2002·Human Reproduction·I A J van RooijA P N Themmen
Mar 18, 2003·Human Reproduction Update·B C TarlatzisJ Bontis
Jan 26, 2006·Endocrine Reviews·Nick S MacklonBart C J M Fauser
Aug 8, 2006·Human Reproduction Update·F J BroekmansC B Lambalk
Aug 23, 2006·Human Reproduction·A La MarcaA Volpe
Nov 14, 2006·Human Reproduction Update·A A A FiddelersJ L H Evers
Nov 23, 2006·Fertility and Sterility·Neal G Mahutte, Aydin Arici
Jun 15, 2007·Human Fertility : Journal of the British Fertility Society·Raj MathurJulian Jenkins
Sep 18, 2007·Human Reproduction·J A HuirneC B Lambalk
Nov 17, 2007·Human Reproduction Update·B C J M FauserUNKNOWN Evian Annual Reproduction Workshop Group 2007

❮ Previous
Next ❯

Citations

Jun 26, 2012·Journal of Inherited Metabolic Disease·Cynthia S GubbelsM Estela Rubio-Gozalbo
Sep 22, 2009·Journal of Assisted Reproduction and Genetics·Cheng-Hsuan WuHorng-Der Tsai
May 15, 2010·Journal of Assisted Reproduction and Genetics·Suresh KiniK Joo Thong
Jun 15, 2011·Journal of Assisted Reproduction and Genetics·Rubens FadiniMariabeatrice Dal Canto
Nov 17, 2011·Journal of Assisted Reproduction and Genetics·Hiroyuki HonnmaYoshimasa Asada
May 2, 2012·Journal of Assisted Reproduction and Genetics·M SönmezerR Pabuccu
Nov 26, 2013·Reproductive Biomedicine Online·Krzysztof LukaszukGrzegorz Jakiel
Dec 25, 2013·Reproductive Biomedicine Online·Isabelle StreuliDominique de Ziegler
Dec 28, 2010·Journal de gynécologie, obstétrique et biologie de la reproduction·C Ferté-DelbendeD Dewailly
Dec 15, 2010·Human Reproduction·Majedah Al-AzemiWilliam Ledger
Apr 12, 2011·Human Reproduction·Laura BenagliaLuigi Fedele
May 3, 2011·Human Reproduction·Andrea WeghoferNorbert Gleicher
Jan 13, 2012·Human Reproduction·Scott M NelsonAntonio La Marca
Oct 1, 2013·Human Reproduction Update·Antonio La Marca, Sesh Kamal Sunkara
Feb 9, 2012·Reproductive Biology and Endocrinology : RB&E·Carlo AlviggiDiego Ezcurra
Nov 23, 2012·Reproductive Biology and Endocrinology : RB&E·Joao Batista A OliveiraJose G Franco
Sep 24, 2009·Reproductive Biology and Endocrinology : RB&E·Carlo AlviggiStephen G Hillier
Jun 26, 2010·Reproductive Biology and Endocrinology : RB&E·Norbert GleicherDavid H Barad
Dec 27, 2011·Reproductive Biology and Endocrinology : RB&E·Anne E ChambersSubhasis Banerjee
Jun 23, 2011·Reproductive Biology and Endocrinology : RB&E·Ernesto Bosch, Diego Ezcurra
Feb 8, 2013·Journal of Ovarian Research·Antonio La MarcaAnnibale Volpe
Feb 2, 2013·Journal of Clinical and Diagnostic Research : JCDR·V S KalaiselviPrashanth Krishna G
Feb 8, 2013·Biomarkers in Medicine·Stamatina Iliodromiti, Scott M Nelson
Apr 17, 2014·BioMed Research International·Krzysztof LukaszukDorota Bialobrzeska
Apr 5, 2012·ISRN Obstetrics and Gynecology·Bruno Ramalho de CarvalhoHitomi Miura Nakagava
May 2, 2014·Human Reproduction·S Iliodromiti, S M Nelson
Jan 17, 2014·Human Reproduction Update·Didier DewaillyRichard A Anderson
Aug 6, 2014·Human Reproduction Update·Antonio La Marca, Sesk Kamal Sunkara
Dec 25, 2013·Archives of Gynecology and Obstetrics·Birol VuralSerdar Filiz
Jan 24, 2014·Obstetrics and Gynecology International·Munawar HussainUma Gordon
Mar 1, 2014·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Joan-Carles ArceAntonio La Marca
Mar 1, 2014·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Cem FiciciogluCigdem Kaspar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.